John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$251M |
| 2 |
Eli Lilly
LLY
|
+$246M |
| 3 |
Cisco
CSCO
|
+$226M |
| 4 |
Chevron
CVX
|
+$224M |
| 5 |
Mastercard
MA
|
+$209M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$262M |
| 2 |
XYZ
Block Inc
XYZ
|
+$236M |
| 3 |
Target
TGT
|
+$228M |
| 4 |
TJX Companies
TJX
|
+$222M |
| 5 |
Roku
ROKU
|
+$221M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.4% |
| 2 | Healthcare | 15.24% |
| 3 | Consumer Discretionary | 8.56% |
| 4 | Financials | 8.41% |
| 5 | Industrials | 7.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SWAV
1576
PUT
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $3.07M | 0.01% |
14,900
+3,700
| +33% | +$726K |
|
1577
Public Storage
PSA
$60.7B
| $3.07M | 0.01% |
+10,324
| New | +$3.24M |
|
1578
Regeneron Pharmaceuticals
REGN
$85.3B
| $3.07M | 0.01% |
+5,068
| New | +$3.15M |
|
1579
VistaGen Therapeutics
VTGN
$10.8M
| $3.06M | 0.01% |
37,289
-2,348
| -6% | -$204K |
|
1580
Albemarle
ALB
$16.7B
| $3.06M | 0.01% |
+13,979
| New | +$2.99M |
|
1581
Omeros
OMER
$1.4B
| $3.06M | 0.01% |
221,799
-173,520
| -44% | -$2.6M |
|
1582
CALL
CME Group
CME
$100B
| $3.06M | 0.01% |
15,800
+12,600
| +394% | +$2.55M |
|
|
SPR
1583
PUT
DELISTED
Spirit AeroSystems
SPR
| $3.04M | 0.01% |
68,800
-40,600
| -37% | -$1.7M |
|
1584
PUT
iQIYI
IQ
$975M
| $3.04M | 0.01% |
378,300
+306,600
| +428% | +$3.18M |
|
1585
uniQure
QURE
$3.29B
| $3.04M | 0.01% |
+94,855
| New | +$2.89M |
|
1586
Lincoln Electric
LECO
$15.4B
| $3.03M | 0.01% |
23,545
+7,770
| +49% | +$1.06M |
|
|
DHC
1587
Diversified Healthcare Trust
DHC
$1.94B
| $3.03M | 0.01% |
893,725
+468,698
| +110% | +$1.77M |
|
1588
PUT
B&G Foods
BGS
$284M
| $3.02M | 0.01% |
101,100
+59,000
| +140% | +$1.77M |
|
1589
PUT
OneMain Financial
OMF
$7.23B
| $3.02M | 0.01% |
54,600
+37,100
| +212% | +$2.16M |
|
1590
Mercer International
MERC
$26.9M
| $3.01M | 0.01% |
260,024
-13,082
| -5% | -$152K |
|
1591
Broadridge
BR
$21.1B
| $3.01M | 0.01% |
+18,053
| New | +$3.07M |
|
|
LADR
1592
Ladder Capital
LADR
$1.27B
| $3.01M | 0.01% |
272,119
+29,540
| +12% | +$331K |
|
1593
CALL
Kohl's
KSS
$2.08B
| $3M | 0.01% |
63,600
+32,600
| +105% | +$1.74M |
|
1594
CALL
InMode
INMD
$869M
| $2.98M | 0.01% |
37,400
-32,200
| -46% | -$1.97M |
|
1595
PUT
BlackBerry
BB
$4.48B
| $2.98M | 0.01% |
306,300
+292,300
| +2,088% | +$3.06M |
|
|
AXON
1596
CALL
Axon Enterprise
AXON
$48.5B
| $2.98M | 0.01% |
17,000
+15,000
| +750% | +$2.72M |
|
1597
CALL
Progressive
PGR
$130B
| $2.97M | 0.01% |
32,900
+29,900
| +997% | +$2.85M |
|
1598
International Paper
IP
$21.7B
| $2.96M | 0.01% |
+55,901
| New | +$3.11M |
|
1599
CALL
Fulgent Genetics
FLGT
$535M
| $2.96M | 0.01% |
32,900
-1,900
| -5% | -$173K |
|
1600
Ouster
OUST
$2.58B
| $2.96M | 0.01% |
+40,398
| New | +$3.73M |
|
Similar funds
John Overdeck's Q3 2021 Portfolio in Review
As of Q3 2021, John Overdeck held 4,966 positions worth $44.7B, up 1.5% from $44.1B the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.
John Overdeck deployed $1.71B of net new capital in Q3 2021, opening 996 new positions and adding to 1,597 existing holdings. Its largest new stake was PayPal: 884,227 shares worth $230M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Block Inc, an estimated $236M trimmed.
- John Overdeck's largest Q3 2021 buy was PayPal: 884,227 shares worth $230M.
- John Overdeck added most to Cisco in Q3 2021, an estimated $226M increase.
- John Overdeck's biggest Q3 2021 reduction was Block Inc, cutting an estimated $236M.
- John Overdeck fully exited Pfizer in Q3 2021, selling an estimated $262M.
- John Overdeck's ten largest holdings make up 5.2% of its $44.7B portfolio in Q3 2021.
- John Overdeck opened 996 new positions and closed 790 in Q3 2021.
- John Overdeck's portfolio value rose 1.5% quarter-over-quarter to $44.7B.
Based on Two Sigma Investments's 13F filing for Q3 2021, filed 15 Nov 2021.